Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
批准号:
8473655
负责人:
Deepak Kaushal
金额:
$73.04万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2015-05-31
关键词:
Acquired Immunodeficiency SyndromeAcuteAddressAerosolsAgeAlveolarAnabolismAnimalsAntitubercular AgentsAttenuatedAutopsyBacillus (bacterium)BeliefBiological AssayBody TemperatureC-reactive proteinCCL19 geneCCL2 geneCCL7 geneCD4 Positive T LymphocytesCatabolismCaviaCell WallCellsCessation of lifeCharacteristicsCholesterolChromosomesChronicClinicalCommunicable DiseasesConfocal MicroscopyDNA RepairDefectDevelopmentDiseaseDoseDrug resistanceEmergency SituationEnvironmentEnzyme-Linked Immunosorbent AssayExhibitsFailureFamilyFatty AcidsGenesGeneticGenomeGranulomaGranulomatousGrowthHistopathologyHumanHypersensitivity skin testingHypoxiaImmune systemIn Situ HybridizationIndividualInfectionInflammatoryInterleukin-12IrrigationLesionLibrariesLiverLungLung Lavage FluidMacaca mulattaMammalian CellMeasurementMeasuresMetabolismMinorityModelingMonkeysMusMycobacterium tuberculosisNitrate ReductasesNutrientOperonOutputPathogenesisPathologyPathway interactionsPeptidoglycanPharmaceutical PreparationsPhasePhenotypePhosphotransferasesPhysiologicalPlayPrimatesProcessProductionPulmonary TuberculosisRegulonRelative (related person)ReportingResistanceRestReverse Transcriptase Polymerase Chain ReactionRoleSamplingSerumSimian Acquired Immunodeficiency SyndromeSouthern BlottingSpleenStagingSterolsStressSystemTestingTimeTuberculosisTuberculosis VaccinesVaccinesValidationVirulenceVirulence FactorsVirulentWeightarabanattenuationbasehygromycin Aimmune activationimmunopathologyin vivolipid transportlymph nodesmacrophagemalemembermortalitymouse modelmutantnitrate reductasenonhuman primateperipheral bloodpublic health relevanceresearch studyresponsesensortransposon site hybridizationtuberculosis drugsvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global infectious disease emergency. Each year an estimated 8 million people develop, and about two million people die of TB. Synergy with AIDS, the emergence of drug-resistance and the lack of effective anti-TB drugs and vaccines has worsened this situation. New drugs and vaccines are urgently needed to effectively control TB. This requires a better understanding of how Mtb adapts to a wide-variety of environmental conditions, inevitably faced by it during the various stages of infection. Nonhuman Primates (NHPs), arguably, best model critical aspects of TB. Analysis of the mechanisms employed by Mtb to successfully infect and persist in NHP lungs would therefore be very useful. We studied genes essential for growth/survival of Mtb in the NHP lungs experimentally exposed to high doses of aerosols of an Mtb transposon mutant library. In this acute model of TB, 33.13% of all tested mutants were attenuated for in-vivo growth compared to the mouse model where only ~6% of all mutants are attenuated. The Mtb mutants attenuated for in-vivo survival in primates were involved in the transport of lipid virulence factors; biosynthesis of cell-wall arabinan and peptidoglycan, fatty-acids and polyketides; DNA repair; sterol metabolism and mammalian cell-entry (mce). Our study highlights the various virulence-mechanisms employed by Mtb for infection and to overcome the hostile environment encountered during infection of NHP lungs. We would like to leverage our ability to model the various clinical phases of human TB - acute, pulmonary TB, chronic-progressive TB and latent, asymptomatic TB in NHPs - to study the growth/survival phenotype profiles of Mtb mutants. Further, we would like to better understand the role of two Mtb pathways crucial for virulence and pathogenesis, using the NHP model. These include the mce1/mce4 operons, whose members were among mutants that were attenuated for growth in NHP lungs; and members of the dos regulon, which were surprisingly not attenuated in NHP lungs, in-spite of their well-defined roles in latency, persistence and defense against hypoxia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
-
批准号:10764569
-
项目类别:
-
资助金额:$141.57万
-
财政年份:2023
-
负责人:Deepak Kaushal
-
依托单位:
Basic Science Core - Imaging
-
批准号:10588228
-
项目类别:
-
资助金额:$13.33万
-
财政年份:2022
-
负责人:Deepak Kaushal
-
依托单位:
Basic Science Core - Imaging
-
批准号:10431470
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2022
-
负责人:Deepak Kaushal
-
依托单位:
Establishment of a SPF Rhesus Macaque Colony
-
批准号:10362396
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2021
-
负责人:Deepak Kaushal
-
依托单位:
Baboon model of long term effects of SARS-CoV-2 infection
-
批准号:10413419
-
项目类别:
-
资助金额:$49.97万
-
财政年份:2021
-
负责人:Deepak Kaushal
-
依托单位:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
-
批准号:10444441
-
项目类别:
-
资助金额:$46.62万
-
财政年份:2021
-
负责人:Deepak Kaushal
-
依托单位:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
-
批准号:10757101
-
项目类别:
-
资助金额:$89.79万
-
财政年份:2020
-
负责人:Deepak Kaushal
-
依托单位:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
-
批准号:10440359
-
项目类别:
-
资助金额:$86.92万
-
财政年份:2020
-
负责人:Deepak Kaushal
-
依托单位:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
-
批准号:10211126
-
项目类别:
-
资助金额:$72.03万
-
财政年份:2020
-
负责人:Deepak Kaushal
-
依托单位:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
-
批准号:10083390
-
项目类别:
-
资助金额:$73.47万
-
财政年份:2020
-
负责人:Deepak Kaushal
-
依托单位:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
-
批准号:10380637
-
项目类别:
-
资助金额:$155.86万
-
财政年份:2019
-
负责人:Deepak Kaushal
-
依托单位:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
-
批准号:10614527
-
项目类别:
-
资助金额:$122.56万
-
财政年份:2019
-
负责人:Deepak Kaushal
-
依托单位:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
-
批准号:9902482
-
项目类别:
-
资助金额:$122.56万
-
财政年份:2019
-
负责人:Deepak Kaushal
-
依托单位:
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function
-
批准号:9353941
-
项目类别:
-
资助金额:$87.3万
-
财政年份:2017
-
负责人:Deepak Kaushal
-
依托单位:
Immune Correlates of Protection from TB
-
批准号:9412296
-
项目类别:
-
资助金额:$82.85万
-
财政年份:2017
-
负责人:Deepak Kaushal
-
依托单位:
Immune Correlates of Protection from TB
-
批准号:9513405
-
项目类别:
-
资助金额:$130.13万
-
财政年份:2017
-
负责人:Deepak Kaushal
-
依托单位:
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement
-
批准号:10116897
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2017
-
负责人:Deepak Kaushal
-
依托单位:
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS
-
批准号:9283337
-
项目类别:
-
资助金额:$73.46万
-
财政年份:2016
-
负责人:Deepak Kaushal
-
依托单位:
Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection
-
批准号:8897566
-
项目类别:
-
资助金额:$46.72万
-
财政年份:2015
-
负责人:Deepak Kaushal
-
依托单位:
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS
-
批准号:9036931
-
项目类别:
-
资助金额:$89.52万
-
财政年份:2015
-
负责人:Deepak Kaushal
-
依托单位:
海外基金